FIELD: medicine, oncology. SUBSTANCE: invention relates to the use of benzotetrazine-1,3-dioxide and its bromo-derivatives as inhibitors of platelet aggregation showing antimetastatic effect. EFFECT: enhanced effectiveness of treatment. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ANTHRA[2,1-D]ISOTHIAZOLE-3,6,11-TRIONE | 2002 |
|
RU2213744C1 |
IRREVERSIBLE INHIBITOR OF SARCOPLASMIC RETICULUM Ca-ADENOSINE TRIPHOSPHATASE | 2001 |
|
RU2194756C1 |
METHOD FOR INHIBITION OF CASPASE ACTIVITY | 2002 |
|
RU2233326C1 |
ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2123526C1 |
(1,2,3-TRIAZOLYL)-1,2,3-OXADIAZOLE DERIVATIVES POTENTIATING NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLAZE | 2000 |
|
RU2158265C1 |
IRREVERSIBLE INHIBITOR OF [H, K]-ADENOSINE TRIPHOSPHATASE | 2001 |
|
RU2186108C1 |
AGENT EXHIBITING ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2014 |
|
RU2573379C1 |
AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
DERIVATIVES OF TETRAFURAZANO-[3,4-B:3',4'-F:3'',4''-J:3''',- -4'''-N]-[1,4,5,8,9,12,13,16]-OCTAAZABICYCLO-[14,2,2]-EICOSA- -4,8,12-TRIENE AND METHOD OF THEIR SYNTHESIS | 2000 |
|
RU2167161C1 |
METHOD FOR DIRECT INHIBITION OF CASPASE ACTIVITY | 2002 |
|
RU2232809C1 |
Authors
Dates
2002-11-20—Published
2001-04-24—Filed